235 related articles for article (PubMed ID: 30576337)
1. Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype.
Jackson M; Serada N; Sheehan M; Srinivasan S; Mason N; Guha M; Avadhani N
PLoS One; 2018; 13(12):e0209489. PubMed ID: 30576337
[TBL] [Abstract][Full Text] [Related]
2. Comparative biology of human and canine osteosarcoma.
Mueller F; Fuchs B; Kaser-Hotz B
Anticancer Res; 2007; 27(1A):155-64. PubMed ID: 17352227
[TBL] [Abstract][Full Text] [Related]
3. MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines.
Lopez CM; Yu PY; Zhang X; Yilmaz AS; London CA; Fenger JM
PLoS One; 2018; 13(1):e0190086. PubMed ID: 29293555
[TBL] [Abstract][Full Text] [Related]
4. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
5. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of P16 expression in canine appendicular osteosarcoma.
Murphy BG; Mok MY; York D; Rebhun R; Woolard KD; Hillman C; Dickinson P; Skorupski K
BMC Vet Res; 2017 Jun; 13(1):189. PubMed ID: 28633676
[TBL] [Abstract][Full Text] [Related]
7. Investigating CXCR4 expression in canine appendicular osteosarcoma.
Fan TM; Barger AM; Fredrickson RL; Fitzsimmons D; Garrett LD
J Vet Intern Med; 2008; 22(3):602-8. PubMed ID: 18466248
[TBL] [Abstract][Full Text] [Related]
8. Comparative Immunology and Immunotherapy of Canine Osteosarcoma.
Mason NJ
Adv Exp Med Biol; 2020; 1258():199-221. PubMed ID: 32767244
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous regression of osteosarcoma in four dogs.
Mehl ML; Withrow SJ; Seguin B; Powers BE; Dernell WS; Pardo AD; Rosenthal RC; Dolginow SZ; Park RD
J Am Vet Med Assoc; 2001 Sep; 219(5):614-7. PubMed ID: 11549088
[TBL] [Abstract][Full Text] [Related]
10. What do we know about canine osteosarcoma treatment? Review.
Szewczyk M; Lechowski R; Zabielska K
Vet Res Commun; 2015 Mar; 39(1):61-7. PubMed ID: 25422073
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and predictive biomarkers of canine osteosarcoma.
Selvarajah GT; Kirpensteijn J
Vet J; 2010 Jul; 185(1):28-35. PubMed ID: 20493743
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy of canine osteosarcoma with canine bone marrow stem cells, bone morphogenetic protein and carboplatin in an in vivo model.
Rici REG; Will SEAL; Luna ACL; Melo LF; Santos AC; Rodrigues RF; Leandro RM; Maria DA
Vet Comp Oncol; 2018 Dec; 16(4):478-488. PubMed ID: 29781255
[TBL] [Abstract][Full Text] [Related]
13. Update on the biology and management of canine osteosarcoma.
Chun R; de Lorimier LP
Vet Clin North Am Small Anim Pract; 2003 May; 33(3):491-516, vi. PubMed ID: 12852233
[TBL] [Abstract][Full Text] [Related]
14. Updates in Osteosarcoma.
Bryan JN
Vet Clin North Am Small Anim Pract; 2024 May; 54(3):523-539. PubMed ID: 38158305
[TBL] [Abstract][Full Text] [Related]
15. Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma.
Morello E; Martano M; Buracco P
Vet J; 2011 Sep; 189(3):268-77. PubMed ID: 20889358
[TBL] [Abstract][Full Text] [Related]
16. ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma.
Cam M; Gardner HL; Roberts RD; Fenger JM; Guttridge DC; London CA; Cam H
Oncotarget; 2016 Jul; 7(30):48533-48546. PubMed ID: 27391430
[TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Analyses for Osteosarcoma in Leonberger Dogs Reveal the
Letko A; Minor KM; Norton EM; Marinescu VD; Drögemüller M; Ivansson E; Megquier K; Noh HJ; Starkey M; Friedenberg SG; Lindblad-Toh K; Mickelson JR; Drögemüller C
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946912
[TBL] [Abstract][Full Text] [Related]
18. Global gene expression analysis of canine osteosarcoma stem cells reveals a novel role for COX-2 in tumour initiation.
Pang LY; Gatenby EL; Kamida A; Whitelaw BA; Hupp TR; Argyle DJ
PLoS One; 2014; 9(1):e83144. PubMed ID: 24416158
[TBL] [Abstract][Full Text] [Related]
19. Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
McMahon MB; Bear MD; Kulp SK; Pennell ML; London CA
Am J Vet Res; 2010 Jul; 71(7):799-808. PubMed ID: 20594083
[TBL] [Abstract][Full Text] [Related]
20. Bridging the gap between experimental animals and humans in osteosarcoma.
Withrow SJ; Khanna C
Cancer Treat Res; 2009; 152():439-46. PubMed ID: 20213406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
